1,298 material Form 8-K filings that 1,057 companies we cover made with the SEC in April 2026, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Banner Corporation signed a merger agreement on April 30, 2026, to acquire Pacific Financial Corporation, the holding company for Bank of the Pacific, in an all-stock transaction. The companies said the combined company is expected to have about $18 billion in assets, and the deal is expected to close in the third quarter of 2026, subject to shareholder and regulatory approvals.
Each Pacific Financial share converts into 0.2633 Banner shares; the companies cite an implied $17.44 per share based on Banner's $66.25 close on April 29, 2026.
The transaction is valued at about $177 million; Pacific Financial shareholders are expected to own about 7% of the combined company.
Pacific Financial must pay Banner a $6.3 million termination fee in certain circumstances.
Closing requires approval by two-thirds of Pacific Financial shareholders and regulatory approvals, including from the Federal Reserve Board and the FDIC; the companies expect closing in the third quarter of 2026.
Acadia Pharmaceuticals said its Head of Research and Development, Elizabeth H.Z. Thompson, Ph.D., plans to retire for personal reasons. She will stay in the role until a successor is appointed and then serve as a consultant through at least the end of 2026, including through the planned Phase 2 readout of remlifanserin in Alzheimer's disease psychosis. The filing matters to shareholders because it changes leadership of the company's research program during a key clinical period.
Dr. Thompson informed the company of her planned retirement on April 27, 2026, and the company announced it on April 30, 2026.
She will remain Head of Research and Development until a successor is appointed, then serve as a consultant through at least the end of 2026.
The company has initiated a search for a replacement; no successor is named in the filing.
The Phase 2 remlifanserin study in Alzheimer's disease psychosis continues to recruit and remains blinded, and the company does not yet know outcomes.
SIM Acquisition Corp. I has moved its extraordinary general meeting from May 1, 2026 to May 7, 2026. The meeting will vote on extending the deadline for completing an initial business combination from July 11, 2026 to July 12, 2027, and shareholder redemption deadlines were also pushed back to May 5, 2026.
Meeting moved from Friday, May 1, 2026 at 10:00 a.m. to Thursday, May 7, 2026 at 3:00 p.m. Eastern Time
Extension Amendment Proposal would extend the business combination deadline from July 11, 2026 to July 12, 2027
Shareholder redemption deadline extended to Tuesday, May 5, 2026 at 5:00 p.m. Eastern Time
On April 30, 2026, Intel issued $6.5 billion of senior notes in five tranches maturing between 2031 and 2066, with net proceeds of approximately $6.47 billion before expenses. The debt was sold under an underwriting agreement dated April 27, 2026, and adds to Intel's long-term borrowings, which shareholders will need to service over time.
Five tranches: $1.0 billion of 4.650% notes due 2031, $1.0 billion of 5.000% notes due 2033, $2.25 billion of 5.300% notes due 2036, $1.75 billion of 6.125% notes due 2056, and $500 million of 6.200% notes due 2066
Approximate net proceeds of $6.47 billion, before expenses and after underwriting discounts
Offering registered under a Form S-3 filed January 23, 2026; notes issued under a supplemental indenture with Computershare Trust Company as trustee
Underwriter representatives include Citigroup Global Markets Inc., J.P. Morgan Securities LLC, Barclays Capital Inc., BofA Securities, Inc., and Deutsche Bank Securities Inc.
On April 30, 2026, AT&T closed the sale of five series of Global Notes with total principal of $6.0 billion, maturing from 2033 to 2066 and carrying coupons from 4.750% to 6.300%. The notes were issued under an underwriting agreement dated April 23, 2026, and registered under an existing Form S-3 shelf. The filing adds $6.0 billion of debt obligations for shareholders to consider, but it reports no change to earnings or guidance.
Five tranches: $750 million 4.750% notes due 2033, $1.75 billion 5.250% due 2036, $500 million 5.850% due 2046, $2.0 billion 6.200% due 2056, and $1.0 billion 6.300% due 2066
Underwriting agreement dated April 23, 2026, with BBVA Securities, J.P. Morgan, Mizuho, Santander, SG Americas and SMBC Nikko as representatives
Notes issued under a 2013 indenture with The Bank of New York Mellon Trust Company, N.A., as trustee
At its April 28, 2026 annual meeting, Wells Fargo shareholders elected all 12 director nominees and approved an amendment and restatement of the 2022 Long-Term Incentive Plan. They also approved executive pay on an advisory basis and ratified KPMG LLP as the independent auditor for 2026. All six shareholder proposals failed to win majority support, with the highest, a call for an independent chair, receiving 33.90% in favor.
Amended 2022 Long-Term Incentive Plan approved with 95.93% of votes cast for or against (2,337,239,396 for; 99,219,067 against)
Advisory say-on-pay vote approved with 65.53% of votes cast for or against (1,604,792,488 for; 831,262,731 against)
KPMG LLP ratified for 2026 with 93.60% in favor; all six shareholder proposals fell short of majority support
Full text of the amended plan is filed as Exhibit 10(a)
Perrigo completed the sale of its Dermacosmetics branded business to Karo Healthcare on April 30, 2026. Karo paid €305.6 million in upfront cash, including €5.6 million in net working capital adjustments, with up to €27.0 million more contingent on net sales milestones over three years. The company says the net proceeds will be used primarily to reduce debt.
Closed April 30, 2026, with upfront cash of €305.6 million, including €5.6 million in net working capital adjustments
Up to €27.0 million in additional contingent consideration, tied to net sales milestones over three years
Net proceeds expected to be used primarily to reduce debt, according to CEO Patrick Lockwood-Taylor
Business generated about €120 million in net sales in calendar 2025, or about 5% of adjusted operating income
PayPal announced on April 29, 2026 a strategic reorganization into three business units, along with leadership changes. EVPs Michelle Gill and Diego Scotti will leave the company, with Gill's departure effective June 2, 2026. The company said it will provide more details on the new operating model during its May 5 earnings call.
Effective June 2, 2026, Michelle Gill ceases to serve as EVP, General Manager, Small Business and Financial Services, and Diego Scotti ceases to serve as EVP, General Manager, Consumer Group.
Gill's separation and release agreement is dated April 27, 2026, and makes her eligible for severance under the Executive Change in Control and Severance Plan for a termination without cause.
The reorganization moves PayPal to a three-business model: Checkout Solutions & PayPal, Consumer Financial Services & Venmo, and Payment Services & Crypto.
Frank Keller was named President, Checkout Solutions & PayPal, and Alexis Sowa and Jeff Pomeroy were named interim leads of two of the new units.
Spire Inc. completed the sale of Spire Marketing Inc., its gas marketing subsidiary, to Boardwalk Pipelines, LP on April 30, 2026, for $215.0 million in cash, subject to customary post-closing adjustments. The company said the proceeds partly fund its acquisition of the Piedmont Natural Gas Tennessee business and general corporate purposes, and that the sale sharpens its focus on regulated natural gas utilities.
Sale price: $215 million in cash, subject to customary post-closing adjustments
Transaction completed and effective April 30, 2026, following the March 28, 2026 purchase agreement
Spire Marketing employees and clients move to Boardwalk Continuum Marketing, LLC; Pat Strange continues as president
Proceeds used to partially fund the Piedmont Natural Gas Tennessee business acquisition and for general corporate purposes
Fluor's subsidiary FDEE Consulting entered a consulting agreement on April 26, 2026 with Mark E. Fields, the company's former Group President, Strategic Projects. He will provide advisory services for up to six months starting April 27, 2026, at $670 per hour. The filing shows a limited, short-term arrangement with no financial figures beyond the hourly rate.
Consulting agreement dated April 26, 2026, between FDEE Consulting, Inc. and Mark E. Fields
Services at $670 per hour for up to six months, beginning April 27, 2026
Full agreement to be filed as an exhibit to the Form 10-Q for the quarter ended June 30, 2026
Teleflex said Jason Weidman, previously a senior leader at Medtronic, will become President and Chief Executive Officer on June 8, 2026, succeeding interim CEO Stuart Randle, who will remain on the Board. Weidman is also expected to join the Board as a director at that time. The filing's compensation terms include a $1 million base salary and a $7 million sign-on restricted stock grant, which shareholders may track in future proxy and SEC filings.
Start date is June 8, 2026; Weidman is expected to join the Board as a director on that date.
Offer letter dated April 26, 2026 provides a $1 million base salary and a target annual bonus of 125% of base salary.
Sign-on restricted stock grant has a grant date fair value of $7 million; stock options have a grant date fair value of $1 million.
Chairman Stephen Klasko said the appointment follows the divestitures and the planned $1 billion share buyback and $800 million debt paydown.
At its April 29, 2026 annual meeting, Carlisle Companies stockholders elected Sheryl D. Palmer and Jesse G. Singh as directors, approved on an advisory basis the 2025 executive pay, and ratified Deloitte & Touche LLP as auditor for 2026. Director Jonathan R. Collins resigned, effective after the meeting, after a change in his employment, and the company said the departure was not due to any disagreement with the company. Executive Vice President Scott C. Selbach also retired on April 28, 2026.
Sheryl D. Palmer received 31,348,097 votes for and 3,257,426 against, and Jesse G. Singh received 32,292,836 for and 2,306,055 against.
Advisory vote on 2025 executive compensation: 30,209,063 for and 4,331,231 against.
Deloitte & Touche LLP ratified as independent auditor for 2026 with 37,101,448 votes for and 132,073 against.
Board fixed the number of directors at seven following Collins' resignation; Selbach retired April 28, 2026 after more than 35 years.
Match Group's board appointed Raina Moskowitz as a director, effective at the 2026 annual meeting, filling the vacancy left by Pamela S. Seymon's previously announced resignation. The filing says the board has not yet decided which committees she will join, and it discloses no related party transactions.
Raina Moskowitz appointed to the board on April 29, 2026, effective at the 2026 annual meeting
Term expires at the 2027 annual meeting of stockholders
Fills vacancy from Pamela S. Seymon's resignation, also effective at the 2026 annual meeting
Manuel Bronstein to stand for election to the board at the 2026 annual meeting, as announced February 17, 2026
At its April 30, 2026 annual meeting, ARMOUR stockholders approved a Fourth Amended and Restated Stock Incentive Plan that adds 1,000,000 shares for issuance, and elected all eight director nominees. Stockholders also ratified Deloitte & Touche LLP as auditor for 2026 and approved 2025 executive compensation on a non-binding advisory basis. The share increase raises the pool available for equity awards, which affects existing shareholders through potential dilution.
Plan adds 1,000,000 shares; only 3,506 shares remained available for grant as of March 19, 2026
Plan sets a ten-year term ending April 29, 2036 and adds a clawback provision
Say-on-pay approved with 48,910,162 votes for and 2,512,562 against
Stockholders voted for one-year frequency of future advisory votes on executive compensation (50,596,296 votes)
SM Energy completed the sale of about 61,000 net acres in Webb County, Texas, to Caturus Energy on April 30, 2026, for a cash purchase price of $950 million, with net cash proceeds of about $900 million after preliminary adjustments. The company plans to use the proceeds to redeem in full $819 million of its 2026 senior notes at par, which it says advances its $1.0 billion-plus divestiture target and its goal of strengthening the balance sheet.
Sale of about 61,000 net acres in Webb County, Texas, to Caturus Energy closed April 30, 2026, under a purchase agreement signed February 17, 2026.
Net cash proceeds of about $900 million; the final purchase price remains subject to customary post-closing adjustments.
Planned full redemption at par of $819 million of 2026 senior notes: $419 million of 6.75% notes (June 1, 2026) and $400 million of 5.0% notes (May 11, 2026).
Lender commitments of $2.5 billion and a borrowing base of $5.0 billion were reaffirmed after the sale.
Phibro Animal Health entered into Amendment No. 1 to its credit agreement with Coöperatieve Rabobank U.A., New York Branch, on April 28, 2026. The amendment increases the revolving credit commitment by $125 million, from $310 million to $435 million, giving the company more borrowing capacity under its existing facility.
Revolving credit commitment rose by $125 million, from $310 million to $435 million
Amendment No. 1 is dated April 28, 2026, and amends the Original Credit Agreement dated July 3, 2024
Rabobank acts as administrative agent, collateral agent and L/C issuer
At its April 28, 2026 annual meeting, RPC's stockholders re-elected all ten board nominees, ratified Grant Thornton LLP as auditor for 2026, and approved previous CEO and Executive Chairman performance stock unit grants and amendments to the 2024 Stock Incentive Plan. Separately, director Gary Kolstad was appointed to the Audit Committee and to the Human Capital Management and Compensation Committee, where he will chair.
Ten director nominees were elected, including Gary Kolstad, who will chair the Human Capital Management and Compensation Committee.
Grant Thornton LLP ratification: 202,026,703 for and 7,139,463 against.
Non-binding executive compensation vote: 190,731,370 for and 7,647,225 against.
Plan amendments to the 2024 Stock Incentive Plan drew 142,609,503 for and 54,634,966 against, the largest opposition among the amendment and grant votes shown.
ResMed said CFO Brett Sandercock will retire, with Aaron Bloomer, formerly CFO of Exact Sciences, taking over as Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer effective May 4, 2026. The company said the retirement was not the result of any disagreement on operations, policies or practices, and it reiterated its fiscal 2026 outlook alongside the announcement.
Sandercock serves as CFO until May 4, 2026, then as Special Advisor to Chairman and CEO Mick Farrell through December 31, 2026, and in a consulting role through December 31, 2027.
Bloomer, age 40, receives a $725,000 base salary, a $150,000 sign-on bonus and a $3,300,000 long-term performance equity grant when he joins.
Bloomer is also eligible for a $3,300,000 equity grant in November 2026 for fiscal year 2027.
ResMed reiterated fiscal 2026 outlook, including gross margin of 62-63%.
HCA Inc., a wholly owned subsidiary of HCA Healthcare, completed a public offering of $3 billion of senior unsecured notes on April 30, 2026. The notes are guaranteed by HCA Healthcare and are registered under a shelf registration statement, so the filing adds $3 billion of debt for the company group.
Three tranches: $1 billion of 4.700% notes due May 15, 2031; $750 million of 5.000% notes due May 15, 2033; and $1.25 billion of 5.300% notes due May 15, 2036
Interest is payable semi-annually on May 15 and November 15, starting November 15, 2026
Notes are fully and unconditionally guaranteed by HCA Healthcare, Inc. on a senior unsecured basis
Underwriting agreement dated April 27, 2026, with Citigroup, Barclays, BofA Securities and J.P. Morgan as representatives of the underwriters
Ryan Specialty Holdings agreed on April 30, 2026 to enter into an option settlement agreement with the Ryan Stock Option Trust, under which the trust must sell up to approximately $52.3 million of Class A common stock to the company. The arrangement supports stock options granted to certain employees, and the company says it is designed to be net neutral to its outstanding share count, since repurchased shares will be retired.
Trust must sell up to about $52.3 million of Class A common stock to the company, at the May 4, 2026 NYSE closing price
Agreement is to be dated May 5, 2026 and runs through June 9, 2036, unless terminated earlier, including on a change in control
Repurchases close monthly after employee exercises of Executive Chairman Stock Options, which vest from July 1, 2029 and expire May 5, 2036
The trust is a trust of Executive Chairman Patrick G. Ryan and Shirley W. Ryan as trustees
Cognex's board determined on April 29, 2026 that Joerg Kuechen will no longer be deemed an executive officer under SEC rules, though he continues as Head of Mergers and Acquisitions. The same day, shareholders approved every proposal at the 2026 Annual Meeting, including director elections, an amendment to the 2023 Stock Option and Incentive Plan, and the ratification of KPMG LLP as auditor for fiscal 2026.
Kuechen's status change applies to the SEC's executive officer and Section 16 officer definitions; he remains with the company as Head of Mergers and Acquisitions.
Of 167,013,856 shares outstanding and entitled to vote, 153,890,280 were represented at the April 29, 2026 meeting.
Matthew Moschner, Angelos Papadimitriou and Christopher Donato were elected as directors for terms ending in 2029.
Say-on-pay received 109,615,176 for votes and 29,685,048 against; KPMG ratification received 153,641,083 for votes and 83,521 against.
Lumen Technologies entered into supplemental indentures and a parent guarantee agreement on April 30, 2026, providing unconditional senior unsecured guarantees of Level 3's first lien notes and its credit facilities. As a result, Level 3 Parent will stop filing reports with the SEC, and Level 3 will meet its reporting duties by furnishing Lumen's filings, which will include summary financial information of Level 3 Parent. The filing describes the changes as administrative simplification and reports no financial results.
Lumen guarantees Level 3's 6.875% first lien notes due 2033 and 7.000% first lien notes due 2034, subject to release terms in the indentures
Lumen also guarantees Level 3's obligations under its Credit Agreement dated March 22, 2024, with Wilmington Trust as administrative agent
Level 3 Parent, LLC will no longer file reports with the Securities and Exchange Commission
Marcus Theatres Chief Financial Officer Jeffry F. Tomachek will be promoted to president of Marcus Theatres effective May 1, 2026, succeeding Mark A. Gramz, who retires that day after 55 years with the company. Gramz's retirement date was moved from March 31, 2026, as announced on April 7, 2026, and he will then advise the company as an independent contractor.
Mark A. Gramz's retirement date changed from March 31, 2026 to May 1, 2026, per the April 7, 2026 announcement.
Jeffry F. Tomachek, currently CFO of Marcus Theatres, will become president of Marcus Theatres effective May 1, 2026.
Tomachek began at Marcus Theatres in 1998 and was named executive vice president and chief financial officer in 2020.
After retirement, Gramz will continue as an advisor to the company in an independent contractor capacity.
Camden Property Trust entered into replacement at-the-market sales agreements on April 28, 2026, to renew a program that expires May 12, 2026. The agreements allow the company to sell common shares with an aggregate offering price of up to $500 million through five banks and their affiliates. The filing says proceeds may be used for general corporate purposes, including reducing borrowings under its $1.2 billion revolving credit facility.
Program size: common shares with an aggregate offering price of up to $500,000,000
Existing program expires pursuant to its terms on May 12, 2026; agreements dated April 28, 2026
Managers include Deutsche Bank Securities, BMO Capital Markets, Regions Securities, Scotia Capital and Truist Securities
Compensation to each manager will not exceed 1.5% of gross sales price of shares sold through it
At its April 29, 2026 annual meeting, Peapack-Gladstone shareholders elected 13 directors to one-year terms expiring in 2027, and voted on an advisory say-on-pay proposal and ratification of Crowe LLP as the 2026 independent auditor. The company also furnished its annual meeting slides, which cite 2025 core relationship deposit growth of $828 million and net interest income growth of 35%.
Thirteen directors were elected to one-year terms expiring in 2027, including Douglas L. Kennedy and Frank Duffield Meyercord (listed as F. Duffield Meyercord in the filing).
Crowe LLP ratification for fiscal 2026: 15,150,537 for, 168,987 against, 7,762 abstain.
Presentation slides cite 2025 core relationship deposit growth of $828 million and net interest income growth of 35%; the company says it is not undertaking to update the presentation.
Dynamix Corporation announced that its common stock ticker on NASDAQ will change from ETHM to DYNC, with units and warrants moving to DYNCU and DYNCW. The changes take effect at the opening of trading on May 1, 2026. The filing is administrative and does not report any financial results or changes to the company's operations.
Common stock ticker changes from ETHM to DYNC on NASDAQ
Units ticker changes from ETHMU to DYNCU; warrants ticker changes from ETHMW to DYNCW
Ticker changes take effect at the opening of trading on May 1, 2026
Halozyme appointed Darren Snellgrove, currently Vice President, Investor Relations at Johnson & Johnson, as Chief Financial Officer effective June 8, 2026. Interim CFO David Ramsay will move to an advisory role during a brief transition period. The filing discloses a $670,000 base salary, a bonus target of 50% of salary, and new-hire equity awards with a total grant date value of $7.2 million.
Start date is June 8, 2026; he will report to President and CEO Helen Torley.
Base salary of $670,000 and a bonus target of 50% of base salary, prorated in 2026.
New-hire equity totals $7.2 million: $3.2 million in RSUs and $4.0 million in stock options, plus a $350,000 sign-on cash bonus.
Previously CFO of Johnson & Johnson's Pharmaceutical sector from August 2021 to May 2025.
On April 28, 2026, Syntec Optics agreed to sell 2,857,142 shares of common stock at $7.00 per share in an underwritten offering led by H.C. Wainwright & Co., with expected gross proceeds of about $20 million before underwriting discounts and expenses. The offering is expected to close on April 30, 2026, and the company plans to use the net proceeds for acquisitions or investments, working capital, capital expenditures and possibly repaying debt, including a subordinated term note with its majority stockholder. The new shares increase the number of shares outstanding, and the company has agreed to restrictions on further stock issuances for 90 days after closing.
2,857,142 shares priced at $7.00 per share; underwriters purchased them at $6.58 per share
Expected gross proceeds of about $20 million; underwriter has a 30-day option for up to 428,571 additional shares
Closing expected April 30, 2026; proceeds may repay part of a $1,268,732.49 subordinated term note with the majority stockholder
Company agreed not to issue additional common stock for 90 days after closing; underwriter discount is 6.0% of gross proceeds
Walmart agreed to sell $4.2 billion of senior unsecured notes in five new series, maturing in 2029, 2031, 2033 and 2036, through underwriters including Citigroup and J.P. Morgan. The company expects the sale to close on April 30, 2026, with net proceeds of about $4.23 billion before transaction expenses, which adds to its long-term debt.
Total principal of $4,245,848,500 across floating rate notes due 2029, 4.000% notes due 2029, 4.150% notes due 2031, 4.450% notes due 2033 and 4.750% notes due 2036
Net proceeds to the company of $4,230,348,500 after underwriting discounts, before transaction expenses
Pricing agreement dated April 27, 2026; closing expected April 30, 2026; sold under an existing S-3ASR shelf registration
At its April 29, 2026 annual meeting, BorgWarner stockholders elected eight directors, approved the amended and restated 2023 Stock Incentive Plan, and approved the company's named executive officer pay on an advisory basis. The Board also declared a $0.17 per share quarterly cash dividend, which gives shareholders a set cash payment date and record date.
Quarterly cash dividend of $0.17 per share declared April 29, 2026; payable June 15, 2026 to holders of record on June 1, 2026.
Stockholders approved the amended and restated 2023 Stock Incentive Plan, which adds 8.3 million shares reserved for issuance.
All eight director nominees were elected, including Alexis P. Michas with 168,149,322 votes for and 6,986,400 against.
A stockholder proposal on action by written consent received 7,092,158 votes for and 167,086,447 against.
Moving iMage Technologies said CFO William F. Greene retired and resigned effective April 27, 2026, and that the resignation was not due to any disagreement with the company. The board named Bart Bedard as Chief Financial Officer effective the same day, with a $200,000 base salary, a $10,000 signing bonus and 75,000 stock options.
William F. Greene resigned as CFO effective April 27, 2026 and will advise the company through approximately October 2026
Bart Bedard named CFO effective April 27, 2026; base salary $200,000 per year
Bedard's offer includes a $10,000 signing bonus and 75,000 stock options, with 25% vesting immediately and 75% over three years
Offer letter provides full vesting of unvested options upon a change of control
MARA agreed on April 29, 2026, to buy 100% of Long Ridge Energy & Power LLC from FTAI Infrastructure-linked sellers for a base purchase price of approximately $1.5 billion, subject to customary adjustments. The plant, a gas-fired power facility in Hannibal, Ohio, sits beside a data center that MARA already operates, and the deal is expected to close in the second half of 2026, subject to regulatory approvals and other conditions.
Base purchase price of approximately $1.5 billion; the press release says total transaction value includes the assumption of at least $785 million of debt.
Barclays committed to provide a 364-day senior secured bridge term loan of up to $785,000,000 to the Company.
Buyer may owe a $75.0 million termination fee in certain circumstances; either party may terminate after November 30, 2026 (or June 30, 2027 if certain regulatory conditions are not met).
Closing is subject to Hart-Scott-Rodino clearance and Federal Energy Regulatory Commission approval.
Entegris said on April 30, 2026 that Sukhi Nagesh will become Senior Vice President and Chief Financial Officer effective May 18, 2026, succeeding Michael Sauer, who has served as interim CFO since March 1, 2026. Sauer will continue as Vice President, Chief Accounting Officer, and the filing says his departure from the interim role was not the result of any disagreement with the company. For shareholders, this sets a permanent finance chief and discloses his pay terms, but the filing contains no financial results.
Base salary of $590,000 per year, with an annual target bonus of 70% of base salary, prorated for 2026
Sign-on bonus of $200,000, repayable if he resigns voluntarily within 12 months of hire
Initial equity grant with a target grant date value of $2,100,000, split 50% time-based restricted share units and 50% performance share units
Severance if terminated without cause outside a change in control: lump sum equal to annual base salary plus 12 months of subsidized medical coverage
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.